AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation.
Journal:
British journal of cancer
Published Date:
May 1, 2021
Abstract
Smartphone applications ("apps") with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers' claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.
Authors
Keywords
Adult
Algorithms
Artificial Intelligence
Diagnostic Test Approval
Early Detection of Cancer
Europe
European Union
Evidence-Based Medicine
Humans
Mobile Applications
Precancerous Conditions
Risk Assessment
Sensitivity and Specificity
Skin Neoplasms
Smartphone
United States
United States Food and Drug Administration